Catabasis Pharmaceuticals Lands $445,865 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d38fc24b-168c-43f7-9c40-63f2a6b410f7&Preview=1
Date
6/27/2013
Company Name
Catabasis Pharmaceuticals
Mailing Address
One Kendall Square Bldg. 1400E Cambridge, MA 02139
Company Description
At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.
Website
http://www.catabasispharma.com
Transaction Type
Venture Equity
Transaction Amount
$445,865
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended.
M&A Terms
Venture Investor
Undisclosed